Anebulo Pharmaceuticals, Inc. (ANEB) vs TScan Therapeutics, Inc. (TCRX)
- Anebulo Pharmaceuticals, Inc. ANEB 0.00 −100.00%
- TScan Therapeutics, Inc. TCRX 0.23 −4.17%
Anebulo Pharmaceuticals, Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and TScan Therapeutics, Inc. are of similar size ($17.6M and $16.2M). Anebulo Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 13 metrics below, Anebulo Pharmaceuticals, Inc. leads on 10 and TScan Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ANEB | TCRX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,695.15%) | 0.00% |
| Net margin | 0.00% | (1,655.35%) | 0.00% |
| Free cash flow margin | 0.00% | (1,665.18%) | 0.00% |
| Return on equity | (69.69%) | (95.80%) | (56.36%) |
| Return on assets | (63.17%) | (50.09%) | (48.04%) |
| Return on invested capital | 0.00% | (4,588.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack